Invited Faculty
  • Thomas Dörner
    Charite Universitätsmedizin Berlin
    Germany
  • Thomas Dörner is Professor of Rheumatology and Clinical Immunology for Innovative Therapies at Charite University Hospitals Berlin, Germany and group leader of the B cell memory group at the German Research Center of Rheumatology Berlin. He is also board certified in Transfusion Medicine and Hemostaseology and leads the coagulation service at Charite hospitals. After his residency at Charite University Hospitals Berlin, he spent a post-doctoral fellowship at the University of Texas, Southwestern Medical Center at Dallas. There he started research on the molecular aspects of the B cell receptor gene usage in autoimmune diseases which subsequently evolved in comprehensive studies of the role of B cells in autoimmunity incl. defining targets of treatment.
    Currently he has a professorship for Innovative therapeutics in Autoimmune Diseases at Charite Universitätsmedizin Berlin. His current main research topics comprise translational projects in autoimmune diseases with a main focus on the role of cytokines on B cell functions, check-point molecule interactions between B and T cells and searching for genetic modulation of B and plasma cell differentiation as a treatment option.
    Thomas Dörner has received a number of international and national awards, including the Senior Scholar Award of the American Society of Rheumatology, the H Schultze Award of the German League against Rheumatism, the Schoen Award of the German Society of Rheumatology and the Fischer Prize by the NIH.
    He has served as a member of editorial boards of leading journals in rheumatology, including Arthritis & Rheumatism, Arthritis Research & Therapy, Annals of the Rheumatic Diseases, Lupus Science and Medicine, Current Reviews in Rheumatology, Brazilian Journal of Rheumatology, Rheumatology Reviews, European Journal of Immunology and Zeitschrift für Rheumatologie.
    Research & Clinical Focus

    systemic lupus

    B cells

    targeted therapy

    plasma cells

    gene therapy

    • Date Time Room Session Title Lecture Title
    May 18 17:40-18:00 Room Auditorium [Concurrent Session 3] Management Recommendations Cardiovascular disease risk management in SLE/APS